Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

So C Wong

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2014
Targeted in vivo delivery of siRNA and an endosome-releasing agent to hepatocytesMagdolna G Sebestyén, So C Wong, Vladimir Trubetskoy, et al.
Drug Delivery|August 19, 2007
In vivo selection and validation of liver-specific ligands using a new T7 phage peptide display systemJames J Ludtke, Alex V Sololoff, So C Wong, et al.
Molecular Pharmaceutics|August 8, 2006
Hepatocyte targeting of nucleic acid complexes and liposomes by a T7 phage p17 peptideSo C Wong, Darren Wakefield, Jason Klein, et al.
Nucleic Acid Therapeutics|November 28, 2012
Co-injection of a targeted, reversibly masked endosomolytic polymer dramatically improves the efficacy of cholesterol-conjugated small interfering RNAs in vivoSo C Wong, Jason J Klein, Holly L Hamilton, et al.
The Journal of Gene Medicine|May 26, 2006
Mechanism of plasmid delivery by hydrodynamic tail vein injection. I. Hepatocyte uptake of various moleculesMagdolna G Sebestyén, Vladimir G Budker, Tatiana Budker, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2007
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytesDavid B Rozema, David L Lewis, Darren H Wakefield, et al.
Molecular Cancer Therapeutics|October 29, 2017
HIF2α-Targeted RNAi Therapeutic Inhibits Clear Cell Renal Cell CarcinomaSo C Wong, Weijun Cheng, Holly Hamilton, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 19, 2015
Protease-triggered siRNA delivery vehiclesDavid B Rozema, Andrei V Blokhin, Darren H Wakefield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2022
HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and HumansYuanqing Ma, Allison Joyce, Olivia Brandenburg, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Methods in Molecular Biology (Clifton, N.J.)|October 17, 2014
Targeted in vivo delivery of siRNA and an endosome-releasing agent to hepatocytesMagdolna G Sebestyén, So C Wong, Vladimir Trubetskoy, et al.
Drug Delivery|August 19, 2007
In vivo selection and validation of liver-specific ligands using a new T7 phage peptide display systemJames J Ludtke, Alex V Sololoff, So C Wong, et al.
Molecular Pharmaceutics|August 8, 2006
Hepatocyte targeting of nucleic acid complexes and liposomes by a T7 phage p17 peptideSo C Wong, Darren Wakefield, Jason Klein, et al.
Nucleic Acid Therapeutics|November 28, 2012
Co-injection of a targeted, reversibly masked endosomolytic polymer dramatically improves the efficacy of cholesterol-conjugated small interfering RNAs in vivoSo C Wong, Jason J Klein, Holly L Hamilton, et al.
The Journal of Gene Medicine|May 26, 2006
Mechanism of plasmid delivery by hydrodynamic tail vein injection. I. Hepatocyte uptake of various moleculesMagdolna G Sebestyén, Vladimir G Budker, Tatiana Budker, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 27, 2007
Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytesDavid B Rozema, David L Lewis, Darren H Wakefield, et al.
Molecular Cancer Therapeutics|October 29, 2017
HIF2α-Targeted RNAi Therapeutic Inhibits Clear Cell Renal Cell CarcinomaSo C Wong, Weijun Cheng, Holly Hamilton, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|April 19, 2015
Protease-triggered siRNA delivery vehiclesDavid B Rozema, Andrei V Blokhin, Darren H Wakefield, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 3, 2022
HIF2 Inactivation and Tumor Suppression with a Tumor-Directed RNA-Silencing Drug in Mice and HumansYuanqing Ma, Allison Joyce, Olivia Brandenburg, et al.
Pageof 1